The Column's Daily Update is published three (3) times per week.
Axens bought Ketjen out of their catalyst rejuvenation joint venture—one that Ketjen (Albemarle's catalyst business) started 2 decades ago.
Trying to commercialize furans isn't easy, Japan wants to replace some coal with wood-based pellets, and Nouryon is expanding its metal alkyls production.
European MXDA is on pause, the US government took stake in yet another materials producer, and Clariant unveiled a new PET catalyst.
Berkshire is buying OxyChem, Nitron Magnetics is trying to make rare-earth-free permanent magnets with iron nitride, and Coolbrook is still trying to make electric cracking a reality.
Cascade Bio just secured $6m to continue scaling its novel enzyme immobilization technology.
Arkema's new HFO plant in Kentucky, Lockhead Martin is trying to secure germanium supply, and Mura is still kicking despite its cancelled plans with Dow Chemical.
